Why potentially millions of doses of mRNA Covid vaccines are lost in the vials

By and

The messenger RNA (mRNA) vaccines against Covid-19 infection are apparently highly effective, but they are also in too short supply to meet current demand. In France, doctors have found that vials of the mRNA vaccines from Pfizer and Moderna contain more than the indicated number of doses. By collecting the dregs of the bottles, there is the potential of producing millions more doses from existing supplies. But the French health authorities are refusing to authorise the practice. Joseph Confavreux and Caroline Coq-Chodorge report.

Reading articles is for subscribers only. Subscribe now.

Messenger RNA (mRNA) vaccines against Covid-19 infection increasingly appear as potentially the most effective way out of the worldwide crisis caused by the coronavirus. In Israel, the mRNA vaccines are demonstrating their efficacy, at least regarding the most severe forms of Covid-19; after a vast campaign of vaccinations of the elderly with the Pfizer-BioNTech mRNA vaccine, the numbers of their hospitalisations due to Covid-19 infection have fallen dramatically.